Ep. 210 Personalizing ADT Across the Prostate Cancer Spectrum with Dr. Rana McKay

235.61 - 263.102 Dr. Rana McKay

And certainly as we think about underserved, you know, regions of the world where there's a lack of access to drugs and treatments. I think as we think about the GnRH analogs, I think there's been an evolution. Classically, we think of GnRH agonists that have been kind of the backbone of treatment. And if we go back to normal physiology, typically the LH and FSH are released in a